While in vivo studies using xenograft mouse models have shown that CLZ promotes apoptosis and inhibits MMP-9 in breast cancer, repolarizes macrophages, disrupts glycolysis in melanoma, and blocks Ca2+ -activated K+ channels in endometrial cancer, further research is needed. The gene discussed is MMP9; the disease is breast carcinoma.